Fundraising Fox
/Companies
Sign in

Epitopea

Montreal, CA · Founded 2021 · 50 employees on LinkedIn · 11 known investors

Find your way into Epitopea

Sign up to see every warm intro you have to Epitopea

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Epitopea team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.

AI & Machine LearningBiotechHealthtech

Founders & leadership

Epitopea was founded in 2021 by Claude Perreault and Pierre Thibault.

CPClaude Perreault
Claude Perreault
PTPierre Thibault
Pierre Thibault

Investors · 11

Cambridge Innovation Capitallisted by Cambridge Innovation CapitalCambridge · $127K – $12.7M

How we know: a partner's Signal profile · funding news · tech.eu · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

CTI Life Sciences Fund L.P.listed by CTI Life Sciences Fund L.P.Montréal

How we know: CTI Life Sciences Fund L.P.'s portfolio page · Not right? Tell us

adMare BioInnovationsreportedVancouver

How we know: globenewswire.com · Not right? Tell us

Fonds de solidarité FTQreportedMontreal

How we know: tech.eu · Not right? Tell us

Also in the syndicate · 6

CTI Life SciencesHarrington Discovery InstituteHarrington Discovery Institute/University Health HoldingsInvestissement QuébecIRICoRNovateur Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Epi BiologicsEpibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
Epics TherapeuticsEPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.
Predictive OncologyPredictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.

Companies working in the same space as Epitopea.

In the news

Epitopea Closes USD $31 million Pre-Series A Financingglobenewswire.com · Oct 2024News & Events - Epitopeaepitopea.com · Apr 2022

Frequently asked questions

What does Epitopea do?
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.
Who founded Epitopea?
Epitopea was founded by Claude Perreault, Pierre Thibault in 2021.
Who are Epitopea's investors?
Epitopea's investors include Advent Life Sciences, Cambridge Innovation Capital, CTI Life Sciences Fund L.P., adMare BioInnovations, Fonds de solidarité FTQ.
Where is Epitopea headquartered?
Epitopea is headquartered in Montreal, CA.